Literature DB >> 18567946

The early expressed HIV-1 genes regulate DNMT1 expression.

Ben Youngblood1, Norbert O Reich.   

Abstract

DNA methylation-mediated transcriptional regulation is essential for human development and diverse diseases ensue when this process is dysregulated. Viruses, including HIV-1, alter the expression of human DNA methyltransferases (DNMTs) and various T cell-specific genes. Here we show that HIV-1 induction of DNMT1 results from overexpression of the early expressed HIV-1 proteins, and this induction is prevented with resveratrol which interferes with the transcription factor AP1 pathway. The HIV-1 responsive element resides in the 5' most 420 bp of the -1634 to +71 DNMT1 promoter; positioning of this truncated promoter proximal to a hybrid SV40-DNMT1 reporter results in HIV-1-dependent regulation. HIV-1 mediated induction of DNMT1 is not specific to T-cells, and does not require receptor-mediated endocytosis. The characterization of HIV-1 mediated DNMT1 regulation provides a basis for identifying viral and cellular factors necessary for the de novo DNA methylation of cellular genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18567946     DOI: 10.4161/epi.3.3.6372

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  27 in total

1.  VDR hypermethylation and HIV-induced T cell loss.

Authors:  Nirupama Chandel; Mohammad Husain; Hersh Goel; Divya Salhan; Xiqian Lan; Ashwani Malhotra; Joseph McGowan; Pravin C Singhal
Journal:  J Leukoc Biol       Date:  2013-02-06       Impact factor: 4.962

Review 2.  Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond.

Authors:  Daniela Boehm; Melanie Ott
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

3.  Immunoassay and molecular methods to investigate DNA methylation changes in peripheral blood mononuclear cells in HIV infected patients on cART.

Authors:  Adelina Rosca; Gabriela Anton; Luminita Ene; Iulia Iancu; Aura Temereanca; Cristian L Achim; Simona M Ruta
Journal:  J Immunoassay Immunochem       Date:  2016-11-17

4.  Epigenetic Promoter DNA Methylation of miR-124 Promotes HIV-1 Tat-Mediated Microglial Activation via MECP2-STAT3 Axis.

Authors:  Palsamy Periyasamy; Annadurai Thangaraj; Ming-Lei Guo; Guoku Hu; Shannon Callen; Shilpa Buch
Journal:  J Neurosci       Date:  2018-05-14       Impact factor: 6.167

Review 5.  Cutting edge: the etiology of autoimmune thyroid diseases.

Authors:  Deirdre Cocks Eschler; Alia Hasham; Yaron Tomer
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 6.  Genetic and epigenetic mechanisms in thyroid autoimmunity.

Authors:  Alia Hasham; Yaron Tomer
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

7.  Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes.

Authors:  Andrew R DiNardo; Tomoki Nishiguchi; Emily M Mace; Kimal Rajapakshe; Godwin Mtetwa; Alexander Kay; Gugu Maphalala; W Evan Secor; Rojelio Mejia; Jordan S Orange; Cristian Coarfa; Kapil N Bhalla; Edward A Graviss; Anna M Mandalakas; George Makedonas
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422

8.  Genome-wide identification of susceptibility alleles for viral infections through a population genetics approach.

Authors:  Matteo Fumagalli; Uberto Pozzoli; Rachele Cagliani; Giacomo P Comi; Nereo Bresolin; Mario Clerici; Manuela Sironi
Journal:  PLoS Genet       Date:  2010-02-19       Impact factor: 5.917

Review 9.  Chromatin dynamics associated with HIV-1 Tat-activated transcription.

Authors:  Rebecca Easley; Rachel Van Duyne; Will Coley; Irene Guendel; Sherry Dadgar; Kylene Kehn-Hall; Fatah Kashanchi
Journal:  Biochim Biophys Acta       Date:  2009-08-27

10.  Epigenetic modification of FOXP3 in patients with chronic HIV infection.

Authors:  Enass A Abdel-Hameed; Hong Ji; Kenneth E Sherman; Mohamed T M Shata
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.